Vertex Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $1.36B | $569.3M |
| FY2014 | — | $1.08B | $625.3M |
| FY2015 | — | $940.0M | $714.8M |
| FY2016 | — | $1.16B | $1.18B |
| FY2017 | — | $2.03B | $1.67B |
| FY2018 | — | $4.44B | $2.65B |
| FY2019 | — | $6.09B | $3.11B |
| FY2020 | — | $8.69B | $5.99B |
| FY2021 | — | $10.10B | $6.80B |
| FY2022 | — | $13.91B | $10.50B |